Download PDF
Synlett 2007(8): 1274-1278  
DOI: 10.1055/s-2007-977448
LETTER
© Georg Thieme Verlag Stuttgart · New York

Lithium Naphthalenide Induced Reductive Selenenylation of α-Cyano Ketones: A Regiocontrolled Process for α-Phenylseleno Ketones and One-Pot Conversion into Enone System

Jia-Liang Zhu*a, Yen-Chun Koa, Chun-Wei Kuob, Kak-Shan Shia*b
a Department of Chemistry, National Dong-Hwa University, Hualien 974, Taiwan, R.O.C.
Fax: +886(38)633570; e-Mail: jlzhu@mail.ndhu.edu.tw;
b Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 350, Taiwan, R.O.C.
Fax: +886(37)586456; e-Mail: ksshia@nhri.org.tw;
Further Information

Publication History

Received 29 January 2007
Publication Date:
08 May 2007 (online)

    Permissions and Reprints All articles of this category

Abstract

An efficient procedure for the regiocontrolled synthesis of α-phenylseleno ketones has been developed, making use of the lithium naphthalenide induced reductive selenenylation of the α-cyano ketone system as a key operation. Moreover, seleno ketones thus generated in situ, upon subsequent treatment with hydrogen peroxide and acetic acid, could be further converted into the corresponding enones with a high degree of regioselectivity, presumably due to the lithium salt mediated selenoxide syn-elimination process.

Key words

lithium naphthalenide - α-phenylseleno ketones - regio­selectivity - α-cyano ketones - reductive selenenylation

    References and Notes

  • For leading references, see:
  • 1a Larock RC. Comprehensive Organic Transformation   2nd ed.:  Wiley; New York: 1999. 
    CrossrefGoogle Scholar
  • 1b Liotta D. Barnum C. Puleo R. Zima G. Bayer C. Kezar HS. J. Org. Chem.  1981,  46:  2920 
    CrossrefGoogle Scholar
  • 1c Bernardi A. Karamfilova K. Sanguinetti S. Scolastico C. Tetrahedron  1997,  53:  13009 
    CrossrefGoogle Scholar
  • 1d Honda T. Rounds BA. Gribble GW. Suh NY. Wang P. Sporn MP. Bioorg. Med. Chem. Lett.  1998,  20:  2711 
    CrossrefGoogle Scholar
  • 1e Smith ND. Hayashida J. Rawal VH. Org. Lett.  2005,  7:  4309 
    CrossrefGoogle Scholar
  • 2a Kusuda S. Watanabe Y. Ueno Y. Toru T. J. Org. Chem.  1992,  57:  3145 
    CrossrefGoogle Scholar
  • 2b Back TG. Organoselenium Chemistry: A Practical Approach   Oxford University Press; New York: 1999. 
    CrossrefGoogle Scholar
  • 3 Cotgreave IA. Moldeus P. Brattsand R. Hallberg A. Andersson CM. Engman L. Biochem. Pharmacol.  1992,  43:  793 
    CrossrefGoogle Scholar
  • 4a Mugesh G. duMont WW. Sies H. Chem. Rev.  2001,  101:  2125 
    CrossrefGoogle Scholar
  • 4b Nogueira CW. Zeni G. Rocha JBT. Chem. Rev.  2004,  104:  6255 
    CrossrefGoogle Scholar
  • In humans, 25 selenoproteins have been identified, many of which possess unknown functions and remain to be explored. For the leading references, see:
  • 5a Kryukov GV. Castellano S. Novoselov SV. Lobanov AV. Zehtab O. Guigo R. Gladyshev VN. Science  2003,  300:  1439 
    Google Scholar
  • 5b May SW. Exp. Opin. Invest. Drugs  1999,  8:  1017 
    Google Scholar
  • 5c Medina D. Thompson H. Ganther H. Ip C. Nutr. Cancer.  2001,  40:  12 
    Google Scholar
  • 6 Navsariwala VD. Prins GS. Swanson SM. Birch LA. Ray VH. Hedayat S. Lantyit DL. Diamond AM. Proc. Natl. Acad. Sci. U.S.A.  2006,  103:  8179 
    CrossrefGoogle Scholar
  • 7 For recent examples, see: Wang J. Li H. Mei Y. Lou B. Xu D. Xie D. Guo H. Wang W. J. Org. Chem.  2005,  70:  5678 ; and references cited therein
    CrossrefGoogle Scholar
  • 8 Girlanda JC. Keyling BF. Schmitt G. Luu B. Tetrahedron  1998,  54:  7735 
    CrossrefGoogle Scholar
  • 9a Reich HJ. Renga JM. Reich IL. J. Am. Chem. Soc.  1975,  97:  5434 
    Google Scholar
  • 9b Wang W. Mei Y. Li H. Wang J. Org. Lett.  2005,  7:  601 
    Google Scholar
  • 9c Reich HJ. Reich IL. Renga JM. J. Am. Chem. Soc.  1973,  95:  5813 
    Google Scholar
  • 9d Clive DLJ. Chem. Commun.  1973,  695 
    Google Scholar
  • 9e Liotta D. Saindane M. Monahan R. Brothers D. Fivush A. Synth. Commun.  1986,  16:  1461 
    Google Scholar
  • 10 Cossy J. Furet N. Tetrahedron Lett.  1993,  48:  7755 
    Google Scholar
  • 11 Torii S. Uneyama K. Handa K. Tetrahedron Lett.  1980,  21:  1863 
    CrossrefGoogle Scholar
  • 12 For preparing a stock solution of LN, see: Liu HJ. Yip J. Shia KS. Tetrahedron Lett.  1997,  38:  2253 
    CrossrefGoogle Scholar
  • 13 Zhu JL. Shia KS. Liu HJ. Chem. Commun.  2000,  1599 
    CrossrefGoogle Scholar
  • 15 Marshall JA. Peterson JC. Lebioda L. J. Am. Chem. Soc.  1984,  106:  6006 
    CrossrefGoogle Scholar
  • 16 Seishiand T. Hiroyuki Y. Yakugaku Zasshi  1959,  79:  467 
    Google Scholar
  • 17 Kahne D. Collum DB. Tetrahedron Lett.  1981,  22:  5011 
    CrossrefGoogle Scholar
  • 19 Kishi N. Mikami K. Nakai T. Tetrahedron  1991,  47:  8111 
    CrossrefGoogle Scholar
  • 20 Negishi E. Tan Z. Liou SY. Liao B. Tetrahedron  2000,  56:  10197 
    CrossrefGoogle Scholar
  • 21 Kreher UP. Rosamilia AE. Raston CL. Scott JL. Strauss CR. Org. Lett.  2003,  5:  3107 
    CrossrefGoogle Scholar
  • 22 Yanagisawa A. Goudu R. Arai T. Org. Lett.  2004,  6:  428 
    Google Scholar
14

Satisfactory spectral and LC-MS or HRMS analytical data were obtained for all new compounds. A typical experiment is outlined as follows: To a solution of α-cyano ketone 1 (110 mg, 0.55 mmol) in THF (10 mL) at -40 °C was added LN (7.5 mL, 0.365 M, 2.75 mmol) dropwise. The resulting dark green solution was stirred at the same temperature for 20 min followed by addition of phenylselenyl bromide (156 mg, 0.66 mmol) in one portion. The resulting mixture was continued to stir for additional 30 min at -40 °C and then quenched with sat. aq NH4Cl and extracted with EtOAc (2 × 10 mL). The combined extracts were washed with brine, dried with Na2SO4, and concentrated to give the crude residue, which was subjected to flash chromatography on silica gel (EtOAc-n-hexane, 1:50) to afford the corresponding α-phenylseleno ketone 2 as a colorless oil (165 mg, 90%). IR (neat): 1729, 1604, 1577 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.72-2.13 (m, 5 H), 2.59 (ddd, J = 18.1, 8.1, 2.0 Hz, 1 H), 3.08 (d, J = 13.7 Hz, 1 H), 3.27 (d, J = 13.7 Hz, 1 H), 7.08-7.11 (m, 2 H), 7.19-7.25 (m, 3 H), 7.30-7.35 (m, 2 H), 7.39-7.45 (m, 1 H), 7.52-7.61 (m, 2 H). 13C NMR (75 MHz, CDCl3): δ = 18.4, 33.0, 36.1, 41.0, 59.5, 126.5, 126.6, 128.3, 129.0, 129.6, 130.5, 137.6, 138.0, 211.6. MS (EI): m/z = 331.2 [M + 1]. Instead of quenching with sat. aq NH4Cl, after ketone 2 was generated in situ following the aforementioned protocol, AcOH (0.13 mL, 2.21 mmol) and H2O2 (0.43 mL of 35% H2O2, 4.41 mmol) were sequentially added to the above reaction mixture at -40 °C. The resulting solution was then warmed to 0 °C in 40 min and quenched with sat. aq NaHCO3 followed by extraction with EtOAc (2 × 10 mL). The combined organic layers were washed with H2O, brine, dried with Na2SO4, and concentrated to give the crude product, which was purified by flash chromatography on silica gel (EtOAc-n-hexane, 1:25) to give exo-(E)-13 9a,b (81 mg) in 85% yield over two steps.
(E)-2-Benzylidenecyclopentanone (13): IR (neat): 1706, 1622, 1487 cm-1. 1H NMR (300 MHz, CDCl3): δ = 2.04 (m, 2 Η), 2.42 (t, J = 7.9 Hz, 2 H), 2.98 (dt, J = 7.2, 2.7 Hz, 2 H), 7.36-7.44 (m, 4 H), 7.54 (dd J = 7.4, 1.1 Hz, 2 H). 13C NMR (75 MHz, CDCl3): δ = 20.2, 29.4, 37.8, 128.7, 129.3, 130.5, 132.3, 135.6, 136.1, 208.0. HRMS (EI): m/z calcd for C12H12O: 172.0889; found: 172.0877.
2-Allyl-2-phenylselenocycloheptanone (6a): IR (KBr): 3072, 2926, 2855, 1686, 740, 691 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.14-1.27 (m, 1 H), 1.33-1.46 (m, 2 H), 1.61 (dd, J = 14.7, 10.7 Hz, 1 H), 1.73-1.94 (m, 3 H), 2.21-2.30 (m, 2 H), 2.40-2.48, (m, 2 H), 3.17 (td, J = 11.2, 2.4 Hz, 1 H), 5.06 (br d, J = 17.1 Hz, 1 H), 5.14 (br d, J = 10.5 Hz, 1 H), 5.92-6.05 (ddm, J = 17.1, 10.5 Hz, 1 H), 7.26-7.31 (tm, J = 7.2 Hz, 2 H), 7.34-7.41 (m, 1 H), 7.41-7.46 (dm, J = 7.2 Hz, 2 H). 13C NMR (75 MHz, CDCl3): δ = 24.9, 26.3, 30.4, 32.1, 36.9, 39.6, 60.7, 118.2, 127.2, 129.0, 129.4, 135.1, 137.5, 207.3. LC-MS (ES): m/z = 331 [M + 23]+.
(E)-2-Allylidenecycloheptanone (18): IR (neat): 1699, 1613, 1579 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.62-1.80 (m, 6 H), 2.47-2.57 (m, 2 H), 2.62-2.68 (m, 2 H), 5.49 (dd, J = 9.9, 1.7 Hz, 1 H), 5.63 (dd, J = 16.7, 1.7 Hz, 1 H), 6.63 (ddd, J = 16.7, 11.5, 9.9 Hz, 1 H), 7.00 (d, J = 11.5 Hz, 1 H). 13C NMR (75 MHz, CDCl3): δ = 25.3, 27.5, 29.8, 31.3, 43.4, 125.4, 131.6, 135.2, 140.3, 204.8. LC-MS (ES): m/z = 151 [M + 1]+.

18

1-Benzoyl-4,6,6-trimethylcyclohex-3-enecarbonitrile (10): IR (KBr): 2232, 1692, 1596, 1578 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.12 (s, 3 H), 1.21 (s, 3 H), 1.72 (br s, 3 H), 1.96 (d, J = 17.9 Hz, 1 H), 2.31 (d, J = 17.9 Hz, 1 H), 2.58 (br d, J = 17.8 Hz, 1 H), 2.90 (br d, J = 17.8 Hz, 1 H), 5.32 (br s, 1 H), 7.42-7.48 (tm, J = 7.3 Hz, 2 H) 7.52-7.58 (tm, J = 7.3 Hz, 1 H), 8.04-8.08 (dm, J = 7.3 Hz, 2 H). 13C NMR (75 MHz, CDCl3): δ = 22.7, 23.8, 27.7, 33.1, 36.7, 44.0, 53.2, 115.2, 121.7,128.4, 129.1, 132.9, 133.9, 137.5, 195.3. LC-MS (ES): m/z = 253 [M]+.
1-Benzoyl-3,4,6,6-tetramethylcyclohex-3-enecarbonitrile (11): IR (KBr): 2232, 1692, 1595, 1578 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.08 (s, 3 H), 1.20 (s, 3 H), 1.66 (br s, 6 H), 1.90 (d, J = 17.8 Hz, 1 H), 2.38 (br d, J = 18.0 Hz, 1 H), 2.44 (d, J = 17.8 Hz, 1 H), 2.88 (br d, J = 18.0 Hz, 1 H), 7.43-7.48 (tm, J = 7.8 Hz, 2 H), 7.53-7.59 (tm, J = 7.8 Hz, 1 H), 8.04-8.08 (dm, J = 7.8 Hz, 2 H). 13C NMR (75 MHz, CDCl3): δ = 18.4, 19.0, 22.5, 27.7, 36.6, 38.6, 45.7, 51.4, 120.3, 121.8, 125.2, 128.4, 129.1, 132.8, 137.8, 195.4. LC-MS (ES): m/z = 267 [M]+.

23

It was reported by Reich et al.,9a that treatment of compound 2 with H2O2 (8.8 equiv) in CH2Cl2 containing a small portion of pyridine at 25 °C gave rise to a mixture of the exo- and endocyclic enones in a ratio of 1:1.3.